Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mark Kelada"'
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 14, Iss 1, Pp 1222-1228 (2018)
A simple one-pot method for the microwave-assisted synthesis of substituted pyrazolo[1,5-a]pyrimidinones, a core scaffold in many bioactive and pharmaceutically relevant compounds, has been established. A variety of substituents was tolerated at the
Externí odkaz:
https://doaj.org/article/95653daae7064644be314951e69ae0eb
Autor:
Patrick J. Cullen, Brijesh K. Tiwari, Mark Kelada, Julie Rose Mae Mondala, Michael Devereux, Sebnem Gunes, John C. Stephens, James F. Curtin, Robert Devine, Zhonglei He, Furong Tian, Gillian E. Conway, Denis O'Shea, Wenxin Wang, Renee Malone, Clara Charleton, John M.D. Walsh, Gemma K. Kinsella
Publikováno v:
European journal of medicinal chemistry. 224
Pyrazolopyrimidinones are fused nitrogen-containing heterocyclic systems, which act as a core scaffold in many pharmaceutically relevant compounds. Pyrazolopyrimidinones have been demonstrated to be efficient in treating several diseases, including c
Autor:
Conway G, Furong Tian, Renee Malone, Sebnem Gunes, Mondala Jrm, Charleton C, Michael Devereux, Robert Devine, John M.D. Walsh, Brijesh K. Tiwari, James F. Curtin, Mark Kelada, Kinsella Gk, John C. Stephens, Zhonglei He, Patrick J. Cullen, Wang W, O'Shea D
Pyrazolopyrimidinone is a fused nitrogen-containing heterocyclic system, which acts as a core scaffold in many pharmaceutically relevant compounds. Pyrazolopyrimidinones have been demonstrated to be efficient in treating several diseases, including c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a2fceca62af5e5289b0108b259e40c1
https://doi.org/10.1101/2021.02.04.429831
https://doi.org/10.1101/2021.02.04.429831
Autor:
Gemma K. Kinsella, John B. C. Findlay, Siobhán Leonard, John M.D. Walsh, Darren S. D. Martin, Conor J Breen, Mark Kelada, John C. Stephens, R.B. Driver, Robert Devine
Publikováno v:
Articles
The management of blood glucose levels and the avoidance of diabetic hyperglycemia are common objectives of many therapies in the treatment of diabetes. An aryl piperazine compound 3a (RTC1) has been described as a promoter of glucose uptake, in part